INVIVO PUPILLARY CONSTRICTOR EFFECTS OF SUBSTANCE-P IN MAN

被引:16
作者
ALESSANDRI, M [1 ]
FUSCO, BM [1 ]
MAGGI, CA [1 ]
FANCIULLACCI, M [1 ]
机构
[1] A MENARINI PHARMACEUT,DEPT PHARMACOL,RES LABS,I-50131 FLORENCE,ITALY
关键词
D O I
10.1016/0024-3205(91)90266-E
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ocular effects of substance P (SP) were studied in 13 normal volunteers. Various concentrations of SP (0.135, 1.35 and 135-mu-g per 100-mu-l) were instilled into the conjunctival sac and pupillary area changes were evaluated by means of an electronic pupillometer. The ability of SP to modify the mydriasis induced by pretreatment with 1% homatropine eyedrops was also studied. The instillation of SP produced miosis in a dose-dependent manner without provoking any ocular disturbances. Furthermore, the highest concentration tested was unable to reduce the homatropine-induced mydriasis. These findings indicate that SP exerts a pupillokinetic action in humans which probably occurs via a receptor mechanism. Since muscarinic blockade is not overcome by the peptide instillation, the results do not clarify whether SP causes miosis acting on iris muscles and/or cholinergic fibres.
引用
收藏
页码:2301 / 2308
页数:8
相关论文
共 38 条
[1]   POSSIBLE NON-MUSCARINIC MIOTIC ACTION OF ECHOTHIOPHATE IODIDE IN HUMANS [J].
ALESSANDRI, M ;
PIETRINI, U ;
FUSCO, BM ;
NICOLODI, M ;
FANCIULLACCI, M .
PHARMACOLOGICAL RESEARCH, 1989, 21 (03) :285-291
[2]   SUBSTANCE-P CONTRACTS THE HUMAN IRIS SPHINCTER - POSSIBLE MODULATION BY ENDOGENOUS ENKEPHALINASE [J].
ANDERSON, JA ;
MALFROY, B ;
RICHARD, NR ;
KULLERSTRAND, L ;
LUCAS, C ;
BINDER, PS .
REGULATORY PEPTIDES, 1990, 29 (01) :49-58
[3]   EVIDENCE THAT THE CONTRACTILE RESPONSE OF THE GUINEA-PIG ILEUM TO CAPSAICIN IS DUE TO RELEASE OF SUBSTANCE-P [J].
BARTHO, L ;
HOLZER, P ;
LEMBECK, F ;
SZOLCSANYI, J .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 332 (NOV) :157-167
[4]   SYSTEMIC AND INTRAOCULAR UPTAKE OF SPANTIDE, A TACHYKININ ANTAGONIST, FOLLOWING TOPICAL APPLICATION TO THE RABBIT EYE [J].
BEDINGBARNEKOW, B ;
LEANDER, S ;
OHLIN, M ;
NINNPEDERSEN, K ;
ALKNER, U ;
HAKANSON, R .
EXPERIMENTAL EYE RESEARCH, 1990, 50 (01) :21-26
[5]   SUBSTANCE-P, NEUROKININ-A AND NEUROKININ-B IN THE OCULAR RESPONSE TO INJURY IN THE RABBIT [J].
BEDINGBARNEKOW, B ;
BRODIN, E ;
HAKANSON, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (01) :259-267
[6]   SUBSTANCE-P - RELEASE ON TRIGEMINAL NERVE-STIMULATION, EFFECTS IN THE EYE [J].
BILL, A ;
STJERNSCHANTZ, J ;
MANDAHL, A ;
BRODIN, E ;
NILSSON, G .
ACTA PHYSIOLOGICA SCANDINAVICA, 1979, 106 (03) :371-373
[7]   THE EFFECTS OF SENSORY DENERVATION ON THE RESPONSES OF THE RABBIT EYE TO PROSTAGLANDIN-E1, BRADYKININ AND SUBSTANCE-P [J].
BUTLER, JM ;
HAMMOND, BR .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (03) :495-502
[8]   SUBSTANCE-P LEVELS IN NORMAL AND SENSORILY DENERVATED RABBIT EYES [J].
BUTLER, JM ;
POWELL, D ;
UNGER, WG .
EXPERIMENTAL EYE RESEARCH, 1980, 30 (03) :311-313
[9]   LONG-TERM ADMINISTRATION OF A SUBSTANCE-P ANTAGONIST, (D-PRO2, D-TRP7,9)-SP, ABOLISHES THE RESPONSE TO OCULAR TRAUMA [J].
BYNKE, G ;
HAKANSON, R ;
HORIG, J ;
FOLKERS, K .
EXPERIENTIA, 1984, 40 (04) :368-369
[10]  
BYNKE G, 1988, EUROPEAN J PHARM, V91, P259